Zusammenfassung
Bei HIV-Infektion liegt neben einem progressiven T-Zell- auch ein B-Zell-Defekt vor. In den USA wurde deshalb mit dem Einsatz von i.v.-Immunglobulinen (IVIG) bei Kindern mit AIDS begonnen, wie seit langer Zeit als Therapie der angeborenen B-Zell-Defekte üblich.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Amman AJ, Schiffman G, Abrams D et al. (1984) B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 251: 1447–1449
Aygören E, Hach-Wunderle V, Störkel F, Scharrer I (1988) Response to immunoglobulin in therapy (IVIG) in 10 Hemophiliacs with antibodies to HIV-1. XVIII International Congress of the World Federation of Hemophilia. Madrid 1988 (Abstr. Nr. 272)
Belohradsky BH (1981) Klinisch anwendbare Immunglobuline. Fortschritte der Antimikrobiellen/Antineoplastischen Chemotherapie. Futur amed, München
Bernstein LJ, Ochs HD, Wedgwood RJ, Rubinstein A (1985) Defective humoral immunitiy in pediatric acquired immune deficiency syndrome. J Pediatr 107: 352–357
Brückmann C, Auberger K, Gandenberger S, Klose HJ, Köhler-Vajta K, Neumann K, Rosendahl C, Wintergerst U, Belohradsky BH (1988) Continuous i.v. immunoglubulinsubsitution (IVIG) in HIV-positive haemophilic patients. XVIII International Congress of the World Federation of Hemophilia. Madrid 1988 (Abbstr. Nr. 196)
Brunkhorst U, Besse S, Willers H, Deicher H, Schedel I (1988) I.V. gammaglobuline treatment of symptomatic HIV-1 infection. IV. International Conference on AIDS, Stockholm 1988 (Abstr. Nr. 7251)
Bussel JB, Haimi JS (1988) Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gammaglobulin. Am J Hematol 28: 79–84
Calvelli TA, Rubinstein A (1986) Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis 5: 207–210
D’Offizi GPD, Mezzaroma I, Pesce AM, Cherchi M, Luzi G, Aiuti F, Paganelli (1988) Intravenous immunoglobulins (IVIG) in HIV-1 infected patients: a randomised study. IV.International Conference on AIDS, Stockholm 1988 (Abstr. Nr. 7250)
Drake JH, Parmley RT, Britton HA (1987) Loss of hepatitis B antibody in human immunodeficiency virus-positive hemophilia patients. Pediatr Infect Dis 6: 1051–1054
Eyster E, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ (1987) Natural history of human immunodeficiency virus infections in hemophiliacs: Effects of T-cell subsets, platelet counts, and age. Ann Int Med 107: 1–6
Finaud M, Gallais H, Gastaud JA, Tamalet J, Casanova P (1988) Thrombocytopenia H.I.V. mediated is reversible with A.Z.T. therapy. IV. International Conference on AIDS, Stockholm 1988 (Abstr. Nr. 3636)
Gonzaga AL, Bonecker C, Azevedo CB (1988) Treatment of the thrombocytopenic purpura related to the infection of the human immunodeficiency virus (TP/HIV). XVIII International Congress of the World Federation of Hemophilia
Gonzaga AL, Bonecker C, Lima LAA, Murta R (1988) Retrospective study on the use of IgG iv of the same region in hemophiliacs with ARC/AIDS. XVIII International Congress of the World Federation of Hemophilia. Madrid 1988 (Abstr. Nr. 258)
Hague RA, Williams PE, Mok J, Hargreaves F, Brettle RP, Yap PL (1988) Treatment of children born to HIV antibody positive mothers with intravenous immunoglobuline (iv IgG). IV. International Conference on AIDS, Stockhohn 1988 (Abstr. Nr. 7248)
Krueger GRF (1986) Infectious cofactors in HIV-positive individuals and their implication for course and prognosis of acquired immune deficiency. AIFO 12:652–660
Lane HC, Masur H, Lynn CE, Whalen G, Rook AH, Fauci AS (1983) Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309: 453–458
Mosca (1987) Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 325: 67–70
Oksenhendler E, Bierling P, Brossard Y, Schenmetzler C, Girard P-M, Seligmann M, Clauvel J-P (1988) Anti-Rh immunoglobulin therapy for human immunodeficiency virus related immune thrombocytopenic purpura. Blood 71: 1499–1502
Oleske JM, Connor EM, Bobila R, Boland M, Cooper R, Epstein L, Joshi V, Minnefor A (1987) The use of IVIG in children with AIDS. Vox Sang 52:172
Rarick M, Loureiro C, Harb M, Jamin D, Gill P, Singer, Levine A (1988) Intravenous immunoglobuline (IGV) in the treatment of HTV-related thrombocytopenia. IV. International Conference on AIDS, Stockholm 1988 (Abstr. Nr. 7642)
Rossi G, Stellini R, Franceschini F, Gorla R, Cadeo GP, Scalzini A (1988) Prevalence and clinical features of thromobytopenia in the HIV+ population. IV. International Conference on AIDS, Stockholm 1988 (Abstr. Nr. 2125)
Sjamsoedin-Visser EJM, Heijnen CJ, Zegers BJM, Stoop JW (1987) Defect in B-cell function in HTLV III/LAV positive hemophilia patients. Blood 69: 1388–1393
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wintergerst, U. et al. (1989). Immunglobulintherapie bei HIV-infizierten Hämophilen — klinische und immunologische Ergebnisse. In: Landbeck, G., Marx, R. (eds) 19. Hämophilie-Symposion Hamburg 1988. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75053-3_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-75053-3_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-51667-5
Online ISBN: 978-3-642-75053-3
eBook Packages: Springer Book Archive